ATuna Beksac

Papers

1

Total Citations

3

H-Index

1

About

A leading figure in urologic oncology, Dr. Tuna Beksac specializes in the surgical management of complex kidney and prostate cancers, with a particular focus on minimally invasive and robotic-assisted techniques. His major contributions center on optimizing treatment outcomes for challenging renal masses, most notably through his landmark multicenter analysis comparing robot-assisted partial nephrectomy to percutaneous ablation for completely endophytic renal tumors. This work, which provides critical long-term data with a minimum three-year follow-up, has been cited three times and helps guide clinical decision-making for patients with deeply embedded tumors. Beyond this key study, Dr. Beksac has advanced the field by investigating novel surgical approaches and refining patient selection criteria to maximize oncologic control while preserving renal function. His research is distinguished by its practical, evidence-based focus, directly impacting how surgeons approach high-risk nephron-sparing surgery. Through his ongoing clinical and academic work, Dr. Beksac continues to shape the evolution of robotic urologic surgery, offering safer, more effective options for patients with complex genitourinary malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted partial nephrectomy versus percutaneous ablation for completely endophytic renal masses: a multicenter analysis with a minimum 3-year follow-up
3 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 16

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago